Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07582185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tdose Binding and Tocilizumab

Name: Tdose Binding and Tocilizumab — clinical trial record (NCT07582185)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TCZ

StatusNot Yet Recruiting

PhasePhase 4

SponsorCentre Hospitalier Universitaire de Nice

Started2026-06-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated May 12, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Centre Hospitalier Universitaire de Nice

356 trials monitored

See 12 trials at risk

Rheumatoid Arthritis

612 trials monitored

See 11 trials at risk

The investigators aim to evaluate the non-inferiority of administering tocilizumab at a fixed dose versus a weight-based dose in patients with rheumatoid arthritis in remission or with low clinical activity, after 3 months of treatment, as part of a two-center randomized trial.

Trial Details

NCT Number	NCT07582185
Lead Sponsor	Centre Hospitalier Universitaire de Nice
Conditions	Rheumatoid Arthritis
Enrollment	122 participants
Start Date	2026-06-01
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-12